The journey takes about 3 hours and is completely scenic
Providers typically review treatment goals, reported symptoms, overall well-being, lifestyle habits, and clinical response during follow-up appointments
Castronovo C, Rossetti R, Rusconi D, Recalcati MP, Cacciatore C, Beccaria E, et al
Recent studies have shown patients taking GLP-1 medications are up to 68 times more likely to develop NAION and irreversible vision loss compared to those using other diabetes treatments, with over 140 cases now documented in the MDL
If my cardio and overall numbers are good, microdosing is worth it. Julie Stewart is a writer, editor and content strategist with over a decade of experience translating complex topics health and medicine, science and engineering into engaging, accessible stories